Literature DB >> 1913477

Near diploid large bowel carcinomas have better five-year survival than aneuploid ones.

T O Rognum1, E Lund, G I Meling, F Langmark.   

Abstract

One hundred patients who underwent surgery for large bowel carcinoma between 1978 and 1982 were examined by flow cytometric DNA quantitation of fresh tumor specimens and divided into an aneuploid (AN) group of 63 and a near diploid (ND) one of 37. All patients were followed until death (n = 63) or until December 31, 1988. Forty-one patients (65%) with AN tumors died of cancer, as did 12 patients (32%) with ND carcinomas. Thus patients with ND tumors had a better survival rate (P = 0.04) than did those with AN ones. The difference was apparent in Dukes' Stages A, B, and C, but not in Stage D. All patients with tumors in this stage died from their carcinomas irrespective of ploidy group. Multiple regression analyses (Cox) of prognostic factors revealed that the most important prognostic variables were (in descending order) Dukes' Stage D, Dukes' Stage C, and DNA ploidy pattern. Histologic grade was not significant as an independent prognostic variable. These results indicate that the presence of a distinctly aneuploid DNA ploidy pattern in large bowel carcinoma is an important prognostic variable that worsens survival rates significantly.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1913477     DOI: 10.1002/1097-0142(19910901)68:5<1077::aid-cncr2820680528>3.0.co;2-m

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

1.  DNA index and S-phase fraction in curative resection of colorectal adenocarcinoma: analysis of prognosis and current trends.

Authors:  Han-Shiang Chen; Shyr-Ming Sheen-Chen; Chen-Chang Lu
Journal:  World J Surg       Date:  2002-03-01       Impact factor: 3.352

Review 2.  Stage-specific frequency and prognostic significance of aneuploidy in patients with sporadic colorectal cancer--a meta-analysis and current overview.

Authors:  Tilman Laubert; Sandra Freitag-Wolf; Michael Linnebacher; Alexandra König; Brigitte Vollmar; Jens K Habermann
Journal:  Int J Colorectal Dis       Date:  2015-06-09       Impact factor: 2.571

3.  Chromosomal gains and losses in primary colorectal carcinomas detected by CGH and their associations with tumour DNA ploidy, genotypes and phenotypes.

Authors:  P M De Angelis; O P Clausen; A Schjølberg; T Stokke
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

4.  Flow cytometric analysis of ploidy in colorectal cancer: a multicentric experience.

Authors:  R Silvestrini; I D'Agnano; A Faranda; A Costa; G Zupi; M Cosimelli; V Quagliuolo; D Giannarelli; L Gennari; R Cavaliere
Journal:  Br J Cancer       Date:  1993-05       Impact factor: 7.640

5.  The TP53 tumour suppressor gene in colorectal carcinomas. II. Relation to DNA ploidy pattern and clinicopathological variables.

Authors:  G I Meling; R A Lothe; A L Børresen; C Graue; S Hauge; O P Clausen; T O Rognum
Journal:  Br J Cancer       Date:  1993-01       Impact factor: 7.640

6.  Strong HLA-DR expression in large bowel carcinomas is associated with good prognosis.

Authors:  S N Andersen; T O Rognum; E Lund; G I Meling; S Hauge
Journal:  Br J Cancer       Date:  1993-07       Impact factor: 7.640

7.  Strong HLA-DR expression in microsatellite stable carcinomas of the large bowel is associated with good prognosis.

Authors:  T Løvig; S N Andersen; L Thorstensen; C B Diep; G I Meling; R A Lothe; T O Rognum
Journal:  Br J Cancer       Date:  2002-09-23       Impact factor: 7.640

8.  Relationships among tenascin expression, DNA ploidy patterns, and multidrug resistance gene product (P-glycoprotein) in human colon carcinoma.

Authors:  I Sugawara; J Hirakoshi; M Kusakabe; A Masunaga; S Itoyama; T Sakakura
Journal:  Jpn J Cancer Res       Date:  1993-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.